Related Experiment Video
Updated: Aug 14, 2026

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
Published on: January 17, 2025
Management of Staphylococcus aureus infections
David M Bamberger1, Sarah E Boyd
1University of Missouri-Kansas City, School of Medicine, Kansas City, Missouri, USA. bambergerd@umkc.edu
Abstract:
Because of high incidence, morbidity, and antimicrobial resistance, Staphylococcus aureus infections are a growing concern for family physicians. Strains of S. aureus that are resistant to vancomycin are now recognized. Increasing incidence of unrecognized community-acquired methicillin-resistant S. aureus infections pose a high risk for morbidity and mortality. Although the incidence of complex S. aureus infections is rising, new antimicrobial agents, including daptomycin and linezolid, are available as treatment. S. aureus is a common pathogen in skin, soft-tissue, catheter-related, bone, joint, pulmonary, and central nervous system infections. S. aureus bacteremias are particularly problematic because of the high incidence of associated complicated infections, including infective endocarditis. Adherence to precautions recommended by the Centers for Disease Control and Prevention, especially handwashing, is suboptimal.
Insights
Staphylococcus aureus infections, including resistant strains, are a growing concern. New treatments exist, but adherence to basic precautions like handwashing remains suboptimal, increasing patient risk.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Staphylococcus aureus infections present significant challenges due to high incidence, morbidity, and rising antimicrobial resistance.
- Vancomycin-resistant strains and community-acquired methicillin-resistant S. aureus (CA-MRSA) infections are increasingly recognized, posing substantial risks.
- Suboptimal adherence to Centers for Disease Control and Prevention (CDC) recommended precautions, particularly handwashing, exacerbates the problem.
Purpose of the Study:
- To highlight the growing concern of Staphylococcus aureus infections for family physicians.
- To discuss the implications of antimicrobial resistance, including vancomycin resistance and CA-MRSA.
- To review available treatments and the importance of preventive measures.
Main Methods:
- Literature review and synthesis of current data on S. aureus infections.
- Analysis of trends in incidence, morbidity, and antimicrobial resistance.
- Discussion of clinical manifestations and treatment options.
Main Results:
- S. aureus is a common cause of diverse infections, including skin, soft-tissue, and invasive conditions like bacteremia and endocarditis.
- Antimicrobial resistance, notably vancomycin resistance and CA-MRSA, is a significant and increasing issue.
- New antimicrobial agents like daptomycin and linezolid offer treatment options for complex infections.
Conclusions:
- Staphylococcus aureus infections, especially resistant strains, require urgent attention from healthcare providers.
- Effective management necessitates awareness of resistance patterns, appropriate use of new antimicrobial agents, and improved adherence to infection control practices.
- Enhanced preventive strategies, including rigorous hand hygiene, are crucial to mitigate the spread and impact of S. aureus infections.
Related Concept Videos
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Urinary Tract Infection IV: Nursing Management
Mitral Stenosis III: Medical Management